Christopher R. Loose - 26 Jan 2023 Form 4 Insider Report for Frequency Therapeutics, Inc. (FREQ)

Role
Chief Scientific Officer
Signature
/s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose
Issuer symbol
FREQ
Transactions as of
26 Jan 2023
Transactions value $
$0
Form type
4
Filing time
27 Jan 2023, 15:35:43 UTC
Previous filing
19 Aug 2022
Next filing
12 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Restricted Stock Unit Award $0 +105K $0.00 105K 26 Jan 2023 Common Stock 105K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units will vest in four equal annual installments beginning on January 26, 2024.